As the pharmaceutical industry propels forward with transformative therapies and next-generation drug manufacturing, safety, precision, and innovation have never been more critical. This is why we’re excited to share that FPS Pharma is proud to be the Gold Sponsor at the upcoming Veridon Global event 2nd Annual EuroPotent 360 Summit a premier forum where industry leaders, innovators, and change-makers converge to shape the future of healthcare and pharmaceutical technology.
At the heart of FPS Pharma’s mission lies an unwavering commitment to enabling safer and more efficient pharmaceutical processes — especially in handling high-potency active pharmaceutical ingredients (HPAPIs) and antibody-drug conjugates (ADCs). With cutting-edge containment isolators, advanced compliance tools, and next-level engineering solutions, FPS Pharma is empowering manufacturers to operate at new levels of excellence.
Why FPS Pharma Leads in High-Containment and Isolation Technology
Pharmaceutical manufacturing increasingly relies on ultra-precise control over environments where potent compounds are handled. FPS Pharma’s custom containment isolators are engineered to meet this demand, safeguarding both operators and product integrity by creating controlled, sealed environments tailored to customer needs. These isolators are vital for HPAPI and ADC processing — providing top-tier containment (up to Occupational Exposure Band (OEB) levels like OEB 7) and compliance with global regulatory standards such as FDA, EMA, OSHA, and cGMP.
Unlike standard cleanroom systems, containment isolators operate under negative pressure to prevent hazardous compounds from escaping, while also offering ergonomic, integrated designs for ease of operation and maintenance. Whether for sampling, formulation, filtration, or packaging, these systems ensure a safe and seamless interface between complex processes and stringent safety requirements.
Keeping Pace with Ultra-Potent API Manufacturing
As pharmaceutical innovation accelerates, the industry is now dealing with compounds of extraordinary potency — where exposure limits are measured in single-digit nanograms per cubic meter. To meet this challenge, FPS Pharma has pioneered containment systems like OEB 7 isolators, representing the new frontier in ultra-potent API containment. These systems go beyond conventional frameworks to handle the most hazardous materials safely, offering customized solutions that integrate advanced features such as closed transfer systems, automated cleaning (CIP/WIP/SIP), real-time monitoring, and robotics.
These isolators act not only as equipment but as strategic enablers, allowing manufacturers to explore new chemistries and scale operations with confidence — reinforcing FPS Pharma’s role as a trusted partner for pharmaceutical companies and contract development and manufacturing organizations (CDMOs) worldwide.
Ensuring Compliance and Operational Efficiency
In addition to containment systems, FPS Pharma offers innovative tools like GloveXpert, a wireless glove leak tester designed specifically for isolators and Restricted Access Barrier Systems (RABS). This advanced system performs rapid, reliable integrity testing — critical for regulatory compliance (including EU GMP Annex 1 and FDA standards) — while dramatically reducing inspection time and risk of contamination.
With features like pressure decay testing, RFID traceability, integrated Wi-Fi, and compatibility with digital control infrastructure, GloveXpert exemplifies how technology and design converge to elevate safety, efficiency, and confidence in pharmaceutical processing operations.
Looking Ahead: FPS Pharma at Veridon Global
As Veridon Global brings together leaders from across healthcare, life sciences, and technology, FPS Pharma’s role as Gold Sponsor underscores its strategic vision: to help the industry innovate boldly while operating within the highest standards of safety and compliance. From high-containment isolators to next-generation API manufacturing solutions, FPS Pharma continues to push boundaries and redefine what’s possible in pharmaceutical production.
We look forward to meaningful conversations at 2nd Annual EuroPotent 360 Summit — connecting, learning, and co-creating safer, smarter pharmaceutical futures. Stay tuned for more insights and highlights from the event!
Article shared with permission from FPS.
